Skip to main content

Fresenius is a global healthcare group, comprised of the Operating Companies Fresenius Kabi and Fresenius Helios (each with 100% ownership share) and the Investment Companies Fresenius Medical Care (32% ownership share) and Fresenius Vamed (77% ownership share).  

Our Operating Companies put our focus on system-critical healthcare products and services for leading therapies into effect and are geared towards profitability optimization and growth. In line with the role of Fresenius as significant shareholder, our Investment Companies will be focused on financial value management.


Fresenius Kabi

Fresenius Kabi specializes in healthcare products for critically and chronically ill patients. The portfolio includes biopharmaceuticals, clinical nutrition, MedTech products and intravenously administered (IV) generic drugs and fluids.


Fresenius Helios

Fresenius Helios stands for healthcare services and is Europe’s leading private hospital operator. The company includes Helios Germany, Quirónsalud, and the Eugin Group. Helios Germany and Quirónsalud provides services to patients in its hospitals and healthcare centers in Germany, Spain, and Latin America. Eugin offers a wide spectrum of state-of-the-art services in the field of fertility treatments over three continents.  

Fresenius Medical Care

Fresenius Medical Care offers services and products for patients with chronic kidney failure. Dialyzers and dialysis machines are among the most important product lines. In addition, Fresenius Medical Care offers dialysis-related services.


Fresenius Vamed

Fresenius Vamed manages projects and provides services for hospitals as well as other healthcare facilities worldwide and is a leading post-acute care provider in Central Europe. The services are aimed at various areas of healthcare, ranging from prevention and acute care to rehabilitation and nursing.